that can be made. Review the official EMA site for detailed operational guidance and training materials specifically designed for users.

Step 2: Preparation for Submission

The preparation phase is critical for a successful submission. This includes gathering all necessary documents, ensuring compliance with submission guidelines, and preparing the submission dossier.

2.1 Collect Required Documentation

Your submission will typically require various documents, depending on the type of submission (e.g., centralised applications, variations, renewals). Commonly required documents include:

• Application Forms: Complete forms such as the Module 1.2.4 for the initial submission.
• Clinical Data: Summaries and detailed reports from clinical studies.
• Quality Data: Information regarding manufacturing processes, product specifications, and stability data.
• Non-Clinical Data: Documentation of studies related to pharmacodynamics, pharmacokinetics, and toxicology.
• Risk Management Plan: If applicable, include a risk management plan as part of your submission.

2.2 Assess Regulatory Compliance

Once the documents are gathered, ensure that you follow the applicable regulatory guidelines. Compliance with the ICH guidelines is crucial for submissions related to clinical trials. National requirements may also apply, depending on the market authorisation you seek.

2.3 Compile the Submission Dossier

The submission dossier must be compiled according to the EMA guidelines. It is common practice to structure the dossier into Modules, typically known as the Common Technical Document (CTD) format:

• Module 1: Administrative information and prescribing information.
• Module 2: Summaries of the quality, non-clinical, and clinical aspects.
• Module 3: Quality information, including production and control data.
• Module 4: Non-clinical study reports.
• Module 5: Clinical study reports.

Ensure that all documents are properly formatted and labelled, conforming to the submission requirements of the EMA. You may also want to validate your files using submission checklists provided by regulatory bodies.

Step 3: User Registration and Access to the IRIS Platform

To access the IRIS platform, registration is necessary. It ensures that you have the required permissions to submit documents and track submissions.

3.1 Registering on the IRIS Platform

Follow these steps to register:

1. Visit the EMA IRIS portal and navigate to the registration page.
2. Fill in the requisite information, including user type (Organization or Individual) and contact details.
3. Accept the terms and conditions to proceed with your registration.
4. Submit your registration request. You will receive a confirmation email once your registration is approved.

3.2 Setting Up Your User Profile

Upon receiving confirmation, log into your user account and complete the profile setup:

• Update your personal and organizational information, including role and responsibilities.
• Set up two-factor authentication for enhanced security.
• Familiarize yourself with the platform interface and where to find assistance if needed.

Step 4: Submission of the Application through the IRIS Platform

With your dossier prepared and user access established, you can begin the submission process via the IRIS platform.

4.1 Creating a New Submission

To initiate a submission:

1. Log in to the IRIS platform using your credentials.
2. Navigate to the “Submissions” tab and select “Create New Submission.”
3. Select the submission type from the drop-down menu (e.g., MAA, variation, renewal).
4. Input basic information about your product, including the product name, active ingredients, and application number if applicable.

4.2 Uploading the Supporting Documents

The document upload phase is critical and needs attention to detail. Follow these steps:

1. Select the appropriate module and document type for each submission.
2. Upload your documents, ensuring that each file adheres to the format requirements (PDF, Word, etc.).
3. Provide descriptions for each document to enhance clarity for the reviewers.
4. After uploading, utilize the validation tool to check for errors or omissions in your submission before finalizing.

4.3 Validate and Submit

Validation is a key step to confirm your submission meets all regulatory standards. Perform the following tasks:

• Run the built-in validation tool to identify any issues.
• Correct any errors highlighted by the validation process, re-upload documents as necessary.
• Once confident that the submission is complete and compliant, click the “Submit” button.

Step 5: Post-Submission Activities

After submission, take proactive steps to monitor and manage your application.

5.1 Monitor Submission Status

Post-submission, it’s critical to follow up and monitor the status of your application.

• Regularly check the IRIS dashboard for real-time updates on your submission status.
• Set notifications to receive email alerts on status changes or requests for additional information.

5.2 Responding to Regulatory Queries

It’s common for regulatory bodies to have questions regarding your submission:

• Prepare to address any requests for additional information promptly.
• Use the IRIS platform to submit any supplementary materials as requested.
• Maintain clear communication with EMA case officers to facilitate the review process.

5.3 Review and Feedback Incorporation

After the review process, you may receive feedback or requests for changes:

• Be prepared to revise your submission based on reviewer feedback.
• Utilize the IRIS platform to manage and document revisions effectively.
• Document any changes made for future reference or audits.

Step 6: Record Keeping and Compliance Monitoring

Maintaining thorough records and ensuring compliance throughout the submission process is paramount. This is not only best practice but essential in fulfilling audit and regulatory requirements.

6.1 Maintain an Audit Trail

Documentation of each step of your submission process is crucial for compliance:

• Keep logs of submission dates, communications with regulators, and feedback received.
• Archive all submitted documents and any correspondence related to the submission.
• Make use of the IRIS platform’s built-in tracking features to support your audit trail.

6.2 Compliance Assessments

Conduct regular compliance assessments to ensure that your submissions align with current regulatory requirements:

• Review EMA guidelines periodically for updates or changes.
• Implement training sessions for your team on compliance best practices and updates.
• Utilize consultancy services if your organization lacks specific expertise on new regulations.

Step 7: Continuous Improvement and Training

Lastly, engage in continuous improvement and training initiatives to enhance the competencies of your team regarding the IRIS platform and overall regulatory practices.

7.1 Ongoing Training Opportunities

Stay informed about ongoing training opportunities related to the IRIS platform:

• Register for workshops and seminars conducted by the EMA or industry leaders.
• Encourage team participation in webinars focused on regulatory developments.
• Access resources and training materials offered on the EMA IRIS platform website.

7.2 Collect and Implement Feedback

Gather feedback from your team on submission experiences:

• Conduct post-submission reviews to identify challenges encountered during the drafting and submission process.
• Implement changes based on feedback to streamline future submissions.

By following this step-by-step guide, regulatory, QA, clinical, and medical affairs teams can navigate the EMA IRIS platform with confidence, ensuring compliance with pharmaceutical regulations while enhancing submission efficiency.